Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06495658 · ClinicalTrials.gov registry record · NA

Impact of Prebiotics in Ulcerative Colitis

A NA study of Ulcerative Colitis and Crohn Disease, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06495658 is a NA study of Ulcerative Colitis and Crohn Disease that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 70 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06495658, a NA study of Ulcerative Colitis and Crohn Disease, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The cause of inflammatory bowel disease (IBD) is currently unknown, although partly attributed to interactions among genetic risk polymorphisms, environmental factors, gut microbiome, and host immunity. Diet, particularly those with plant-based products, have been shown in prior research to improve gut microbial composition, which has been linked to different IBD-related outcomes. This study is interested in evaluating the impact of prebiotics on gut microbiome composition and gut health in patients with IBD. Dietary composition will be assessed at baseline and over the course of 16 weeks. Participants will be randomized to either consume an 8-week course of prebiotic supplementation beginning at week 0 or week 8. Stool samples will be collected at weeks 0 and 8. The stool will be analyzed for cross-sectional and longitudinal fecal microbial changes associated with different prebiotic and diet consumption patterns in the context of heterogeneous disease characteristics.

Conditions Studied

Ulcerative Colitis Crohn Disease

Interventions

  • DIETARY_SUPPLEMENT Prebiotic

Study Locations (1)

California

  • UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-07-09
Est. Completion 2027-12-31
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06495658

The ClinicalTrials.gov registry entry for NCT06495658 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which Prebiotic is the first listed.

NCT06495658 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06495658 about?

NCT06495658 is a clinical study titled "Impact of Prebiotics in Ulcerative Colitis". The cause of inflammatory bowel disease (IBD) is currently unknown, although partly attributed to interactions among genetic risk polymorphisms, environmental factors, gut microbiome, and host immunity. Diet, particularly those with plant-based products, have been shown in prior research to improve ...

What is the current status of trial NCT06495658?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-07-09. Estimated completion is 2027-12-31.

What conditions does trial NCT06495658 study?

This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease.

What interventions are being tested in trial NCT06495658?

The interventions under investigation include: Prebiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06495658?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06495658 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis

All registered trials for this condition

Crohn Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.